- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01393054
Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension
Study Overview
Detailed Description
The study will be conducted in Geriatric Outpatient Clinic of Cipto Mangunkusumo National Hospital, Jakarta, Indonesia.
Eligibility criteria are men and women over 60 years old and available to participate in the study for 4 weeks with blood pressure higher than 140/90.
Exclusion criteria are renal disease, hepatic failure, dementia and orthostatic hypotension and malignant hypertension.
Outcome measures are systolic and diastolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract twice daily.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Jakarta, Indonesia
- Recruiting
- Cipto Mangunkusumo National Hospital
-
Contact:
- Aulia Rizka, MD
- Phone Number: +628125265600
- Email: dr.auliarizka@yahoo.co.id
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women more than 60 years old
- Systolic Blood Pressure 140 mm Hg AND OR diastolic blood pressure 90 mmHg
- Available during study duration (4 weeks)
Exclusion Criteria:
- Renal failure
- Hepatic failure
- Dementia
- Orthostatic hypotension
- Malignant hypertension
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
systolic blood pressure
Time Frame: 4 weeks
|
We aim to measure the difference in systolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract in elderly with hypertension
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
diastolic blood pressure
Time Frame: 4 weeks
|
We measure the difference of diastolic blood pressure after 4 weeks administration of 300 mg Nigella sativa seed extract in elderly with hypertension
|
4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Aulia Rizka, MD, Faculty of Medicine University of Indonesia
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NS2602
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Addpharma Inc.Completed
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Istituto Auxologico ItalianoRecruitingHypertension,Essential | Hypertension, UncontrolledArgentina, China
Clinical Trials on Nigella sativa
-
Cairo UniversityCompleted
-
Beni-Suef UniversityUniversity of Arizona; Maternity and Children Hospital, MakkahCompletedCovid19 | ImmunodeficiencySaudi Arabia
-
Aga Khan UniversityCompletedHypertension | Diabetes Mellitus | Hypercholesterolemia | Metabolic Syndrome XPakistan
-
Hillel Yaffe Medical CenterUnknownNonalcoholic Steatohepatitis | Liver SteatosisIsrael
-
Sohaib AshrafRecruiting
-
Novatek PharmaceuticalsCompletedCovid19United States
-
Cairo UniversityCompleted
-
Ain Shams UniversityActive, not recruiting
-
University College, LondonKing Abdulaziz UniversityCompleted